EDSA compared with JSPR: revenue, margins and what each company keeps, and the suppliers and customers both name

EDSAEdesa Biotech, Inc.

Mkt capRevenueRevenue

JSPRJasper Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

EDSAEdesa Biotech, Inc.

JSPRJasper Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

EDSA: latest quarter not drawable. JSPR: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only EDSA 0

None

Shared 0

No disclosed counterparties: EDSA.

Only JSPR 1

—PCI Pharma Servicesunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

EDSA, solidJSPR, dashed

EDSAEdesa Biotech, Inc.

2.56▼−5.19%· post 2.70

Mkt cap$24.8M

JSPRJasper Therapeutics, Inc.

0.53▼−1.24%· post 0.53

ClosedOct 30 '26

Mkt cap$14.9M

Compare

ClosedOct 30 '26

EDSAEdesa Biotech, Inc.

JSPRJasper Therapeutics, Inc.

2.56▼−5.19%post 2.70

Price

0.53▼−1.24%post 0.53

$24.8M

Mkt cap

$14.9M

EDSA2.56▼−5.19%vsJSPR0.53▼−1.24%ClosedOct 30 '26